Skip to main content
. 2019 Dec 16;5(2):2055116919891548. doi: 10.1177/2055116919891548

Figure 3.

Figure 3

(a) Exacerbation of pad lesions after steroid discontinuation; and (b) crusting of lesions with underlying purulent discharge